Cleared Traditional

K232123 - MectaLIF Anterior Lag Extension

K232123 is the FDA 510(k) clearance for MectaLIF Anterior Lag Extension by Medacta International S.A.. It is a Class 2 Orthopedic device (product code OVD) cleared through the Traditional 510(k) pathway after a 93-day FDA review.

K232123 · Medacta International S.A. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2023
Decision
93d
Days
Class 2
Risk

K232123 is an FDA 510(k) clearance for the MectaLIF Anterior Lag Extension. Classified as Intervertebral Fusion Device With Integrated Fixation, Lumbar (product code OVD), Class II - Special Controls.

Submitted by Medacta International S.A. (Castel San Pietro, CH). The FDA issued a Cleared decision on October 18, 2023 after a review of 93 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Medacta International S.A. devices

Submission Details

510(k) Number K232123 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 17, 2023
Decision Date October 18, 2023
Days to Decision 93 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
29d faster than avg
Panel avg: 122d · This submission: 93d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OVD Intervertebral Fusion Device With Integrated Fixation, Lumbar
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Lumbar Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft With Or Without Supplemental Fixation.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Medacta USA
Christopher Lussier

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - OVD Intervertebral Fusion Device With Integrated Fixation, Lumbar

All 144
Devices cleared under the same product code (OVD) and FDA review panel - the closest regulatory comparables to K232123.
Omnia Medical TiBrid™-SA System
K240623 · Omnia Medical, LLC · Apr 2024
Anterior Spine Truss System-Stand Alone (ASTS-SA)
K233966 · 4Web Medical, Inc. · Apr 2024
E3D™-A Interbody System
K232432 · Evolution Spine · Jan 2024
Stable-L Standalone Lumbar Interbody System
K231486 · Nexus Spine, LLC · Oct 2023
IdentiTi ALIF Interbody Systems
K232097 · Alphatec Spine, Inc. · Sep 2023
Stable-L Standalone Lumbar Interbody System, Stable-C Interbody System
K232530 · Nexus Spine, LLC · Sep 2023